OTCQB:ACAN - OTCQB:DRUS - OTCQB:ICNAF - OTCQB:MMNFF - OTCQB:PPCB - OTCQX:BDRBF - OTCQX:CSVI - OTCQX:WSTRF - 24/7 Market News

Venture Breakfast Bits, by 24/7 Market News

2018-10-04T10:11:35+00:00 Oct. 4, 2018 10:09AM EST|

Venture Market News for October 4, 2018

  • CSI Reports Growth in Revenues and Net Income for Second Quarter

Computer Services, Inc. (CSI) (OTCQX: CSVI) today reported growth in revenues and net income for the six months and second quarter ended August 31, 2018.  

Full press release

  • Drone USA's Subsidiary Howco Distributing Co. Generated $1.4 Million Revenue to the Defense Logistics Agency, US Navy, Army and Coast Guard Over the Past 10 Days

PINE BROOK, NJ / ACCESSWIRE / October 4, 2018 / Drone USA, Inc. (OTCQB: DRUS) ("Drone USA" or the "Company"), a service provider and reseller of drones and distributor of products to the U.S. Government, today announced that its subsidiary, Howco Distributing ("Howco"), in the last 10 days, shipped products totaling $1.4 million in revenue to the Defense Logistics Agency, the U.S. Navy, Army and Coast Guard. Most of the shipments went to the Defense Logistics Agency and the Army. Many of the products for the Army were earmarked for our allies across the globe.

Full press release

  • MedMen Increases Term Loan Facility to C$100 Million

MedMen Enterprises Inc. (“MedMen” or the “Company”) (CSE: MMEN) (OTCQB: MMNFF) (FSE: A2JM6N) announced today that it has closed an additional tranche of its previously announced senior secured term loan (the “Facility”) with funds managed by Hankey Capital and an affiliate of Stable Road Capital (the “Lenders”). Pursuant to the terms of the Facility, the principal amount of the loan has been increased by C$5,661,920 to C$99,952,190. The principal amount under the Facility will accrue interest at a rate of 7.5 percent per annum, paid monthly, with a maturity date of 24 months following the date of closing. The proceeds from the Facility will be used for acquisitions, capital expenditures and other corporate expenses.

Full press release

  • Propanc Biopharma Initiates European Validation of its Lead Patent

MELBOURNE, Australia, Oct. 4, 2018 /PRNewswire/ -- Propanc Biopharma, Inc. (OTCQB: PPCB) ("Propanc Biopharma" or the "Company"), a clinical stage biopharmaceutical company focusing on development of new and proprietary treatments for cancer patients suffering from solid tumors such as pancreatic, ovarian and colorectal cancers, today announced initiation of European (EP) validation of its lead patent in most major commercial markets in Europe. EP validation is the process of converting a single granted European patent application into a national patent in one or more contracting member and extension states of the European Patent Convention.

Full press release

  • AmeriCann To Operate Large-Scale Cannabis Product Manufacturing Facility in Massachusetts

Company to Produce Branded Cannabis Beverages, Vaporizer Products, Edible and Non-Edible Products and Concentrates

DENVER, CO / ACCESSWIRE / October 4, 2018 / AmeriCann, Inc. (OTCQB: ACAN), an agricultural-technology company that is developing the next generation of eco-friendly start-of-the-art greenhouse cannabis cultivation and processing properties, has announced plans to own and operate a large-scale cannabis manufacturing and processing facility at its 52-acre Massachusetts Medical Cannabis Center (MMCC) in Freetown, MA.

Full press release

  • Bombardier receives order as Siemens' partner and supplier in the expansion of Deutsche Bahn's ICE 4 fleet

Bombardier's supply share is around one third of Deutsche Bahn’s order of 18 7-car trains and 50 rail cars

BERLIN, Oct. 04, 2018 (GLOBE NEWSWIRE) --

Global mobility solution provider Bombardier Transportation will continue to make an important contribution to the expansion of Deutsche Bahn's ICE 4 fleet as a Siemens’ partner and supplier. At the end of September, Bombardier signed a contract with Siemens for further cooperation as a supplier for Deutsche Bahn's new order for 18 7-car ICE 4 trains and 50 powered cars. The contract is valued at approximately 198 million euro ($229 million US). Bombardier’s scope represents around one third of the overall project.

Full press release

  • Empower Clinics Announces US Distribution Agreement with Integrated Cannabis Company

Empower Clinics Inc. (OTC: EPWCF; CSE: EPW; FRA: 8EC), a leading owner and operator of medical cannabis and wellness clinics in the US, today announced a national distribution agreement with Integrated Cannabis Company, Inc. (CSE: ICAN) (OTCQB: ICNAF).

Full press release

  • Western Uranium Corporation Announces Completion of Name Change to Western Uranium & Vanadium Corp

TORONTO and NUCLA, Colo., Oct. 04, 2018 (GLOBE NEWSWIRE) -- Western Uranium Corporation (CSE: WUC) (OTCQX: WSTRF) (“Western” or the “Company”) is pleased to announce that it has completed its name change to Western Uranium & Vanadium Corp. (the “New Name”). The name change was previously announced in a press release issued by the Company on September 27, 2018. The change to the New Name was implemented by the board after having obtained shareholders’ approval at the Company’s Annual General and Special Meeting held in New York City on June 29, 2018.

Full press release

Connect with 24/7 Market News on social media

https://twitter.com/247MarketNewsHQ

https://www.facebook.com/247MarketNewsHQ/

About 24/7 Market News

As a pioneer in digital financial market media, 24/7 Market News (24/7MN) is dedicated to the swift distribution of financial market news and information.  24/7 MN provides comprehensive corporate communications resources and tools to engage the investment community.

DISCLAIMER:

24/7 Market News (24/7MN) is a third party publisher and news dissemination service provider that produces regular sponsored and non-sponsored reports, articles, stock market blogs, and newsletters covering equities listed on the NYSE, NASDAQ and micro-cap exchanges. 24/7MN holds no investment licenses and is NOT a financial advisory firm, investment adviser, analyst, or broker-dealer and does not undertake any activities that would require such registration. 24/7MN's market updates, news alerts and corporate profiles are NOT a solicitation or recommendation to buy, sell or hold securities.

The material in this release is intended to be strictly informational and is NEVER to be construed or interpreted as research material. All readers are strongly urged to perform research and due diligence on their own and consult a licensed financial professional before considering any level of investing in stocks. All material included herein is republished content and based on publicly available information which is believed to be reliable. 24/7MN makes no representations as to the completeness, accuracy, or timeliness of the material provided and all materials are subject to change without notice.   24/7MN and/or its affiliates are not responsible for any gains or losses that result from the opinions expressed and are not liable for any investment decisions by its readers or subscribers. Investors are cautioned that they may lose all or a portion of their investment when investing in stocks.

For further information on 24/7 Market News, please go to www.247marketnews.com 

Forward-Looking Statements

This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may," "future," "plan," or "planned," "will," or "should," "expected," "anticipates," "draft," "eventually," or "projected." You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company's annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and 24/7MN undertakes no obligation to update such statements

CONTACT:

24/7 Market News

Editor@247marketnews.com

Send this to a friend

Hi, this may be interesting you: Kraig Biocraft Laboratories’ New R&D Facility Extends Its Competitive Advantages and Prepares for Large Scale Production! This is the link: https://www.247marketnews.com/kraig-biocraft-laboratories-new-rd-facility-extends-its-competitive-advantages-and-prepares-for-large-scale-production/